SIMILAR PATTERNS OF AMINO ACIDS FOR 5DLW_A_5D5A905

List of similar pattern of amino acids derived from ASSAM search

Hit pattern: 3D amino acid arrangements similar to known drug binding site
Query pattern: Residues from known binding site for annotated drug that match the hit pattern

(Click link on the last column to view superposed patterns of amino acids in NGL viewer)
(Note that only 3-12 residue patterns can be used for ASSAM searches)
Filter list by:
Hit Macromolecule/
Organism		 Pfam Res. Interface HETATM RMSD Dali Z-score Seq. Identity (%) View Dock
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1t9i DNA ENDONUCLEASE
I-CREI

(Chlamydomonas
reinhardtii) 		PF00961
(LAGLIDADG_1) 		5 LEU A  84
PHE A   9
PHE A  43
VAL A  64
TYR A  76
 None
 1.26A 5dlwA-1t9iA:
0.0		 5dlwA-1t9iA:
10.99
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2ivf ETHYLBENZENE
DEHYDROGENASE
ALPHA-SUBUNIT

(Aromatoleum
aromaticum) 		PF00384
(Molybdopterin)
PF01568
(Molydop_binding) 		5 LEU A 606
SER A 607
PHE A 956
ARG A 613
VAL A 193
 None
MD1  A1987 (-4.5A)
None
MD1  A1987 (-3.9A)
None
 1.46A 5dlwA-2ivfA:
0.0		 5dlwA-2ivfA:
21.48
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3mx9 PROTEIN SCV3V2(G19S)

(Chlamydomonas
reinhardtii) 		PF00961
(LAGLIDADG_1) 		5 LEU A  84
PHE A   9
PHE A  43
VAL A  64
TYR A  76
 None
 1.36A 5dlwA-3mx9A:
0.0		 5dlwA-3mx9A:
16.27
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4hi7 GI20122

(Drosophila
mojavensis) 		PF00043
(GST_C)
PF13417
(GST_N_3) 		5 LEU A 112
ARG A  16
HIS A  69
VAL A 172
TYR A 139
 None
None
GSH  A 301 (-4.0A)
None
None
 1.16A 5dlwA-4hi7A:
0.6		 5dlwA-4hi7A:
15.89
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4zg7 ECTONUCLEOTIDE
PYROPHOSPHATASE/PHOS
PHODIESTERASE FAMILY
MEMBER 2

(Homo sapiens) 		PF01033
(Somatomedin_B)
PF01223
(Endonuclease_NS)
PF01663
(Phosphodiest) 		10 LEU A  79
SER A  82
PHE A 211
ARG A 247
LYS A 249
PHE A 250
TRP A 255
TRP A 261
PHE A 275
VAL A 278
 None
4O0  A 908 ( 2.9A)
NKN  A 909 ( 4.7A)
None
4O0  A 908 (-4.0A)
4O0  A 908 (-4.5A)
4O0  A 908 (-3.3A)
4O0  A 908 (-4.4A)
4O0  A 908 (-3.7A)
4O0  A 908 ( 3.5A)
 0.56A 5dlwA-4zg7A:
59.6		 5dlwA-4zg7A:
92.72
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4zg7 ECTONUCLEOTIDE
PYROPHOSPHATASE/PHOS
PHODIESTERASE FAMILY
MEMBER 2

(Homo sapiens) 		PF01033
(Somatomedin_B)
PF01223
(Endonuclease_NS)
PF01663
(Phosphodiest) 		8 PHE A 211
ARG A 247
LYS A 249
PHE A 250
HIS A 252
TRP A 255
TRP A 261
PHE A 275
 NKN  A 909 ( 4.7A)
None
4O0  A 908 (-4.0A)
4O0  A 908 (-4.5A)
4O0  A 908 (-3.7A)
4O0  A 908 (-3.3A)
4O0  A 908 (-4.4A)
4O0  A 908 (-3.7A)
 0.73A 5dlwA-4zg7A:
59.6		 5dlwA-4zg7A:
92.72
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4zg7 ECTONUCLEOTIDE
PYROPHOSPHATASE/PHOS
PHODIESTERASE FAMILY
MEMBER 2

(Homo sapiens) 		PF01033
(Somatomedin_B)
PF01223
(Endonuclease_NS)
PF01663
(Phosphodiest) 		6 PHE A 211
LYS A 249
PHE A 250
HIS A 252
TRP A 255
TYR A 307
 NKN  A 909 ( 4.7A)
4O0  A 908 (-4.0A)
4O0  A 908 (-4.5A)
4O0  A 908 (-3.7A)
4O0  A 908 (-3.3A)
NKN  A 909 (-3.6A)
 1.22A 5dlwA-4zg7A:
59.6		 5dlwA-4zg7A:
92.72
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4zg7 ECTONUCLEOTIDE
PYROPHOSPHATASE/PHOS
PHODIESTERASE FAMILY
MEMBER 2

(Homo sapiens) 		PF01033
(Somatomedin_B)
PF01223
(Endonuclease_NS)
PF01663
(Phosphodiest) 		6 PHE A 211
LYS A 249
PHE A 250
TRP A 255
VAL A 278
TYR A 307
 NKN  A 909 ( 4.7A)
4O0  A 908 (-4.0A)
4O0  A 908 (-4.5A)
4O0  A 908 (-3.3A)
4O0  A 908 ( 3.5A)
NKN  A 909 (-3.6A)
 1.50A 5dlwA-4zg7A:
59.6		 5dlwA-4zg7A:
92.72
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4zg7 ECTONUCLEOTIDE
PYROPHOSPHATASE/PHOS
PHODIESTERASE FAMILY
MEMBER 2

(Homo sapiens) 		PF01033
(Somatomedin_B)
PF01223
(Endonuclease_NS)
PF01663
(Phosphodiest) 		5 SER A 277
PHE A 211
HIS A 252
TRP A 255
TRP A 261
 GOL  A 910 ( 4.4A)
NKN  A 909 ( 4.7A)
4O0  A 908 (-3.7A)
4O0  A 908 (-3.3A)
4O0  A 908 (-4.4A)
 1.45A 5dlwA-4zg7A:
59.6		 5dlwA-4zg7A:
92.72
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5da0 SULPHATE TRANSPORTER
NANOBODY

(Deinococcus
geothermalis;
Lama glama) 		PF00916
(Sulfate_transp)
PF01740
(STAS)
PF07686
(V-set) 		5 LEU A 473
SER A 477
ARG A 483
PHE B  50
VAL A 451
 None
 1.26A 5dlwA-5da0A:
0.0		 5dlwA-5da0A:
19.62